TSHA
Asset Logo

Taysha Gene Therapies Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-22.51%
Annual Growth

4 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Taysha Gene Therapies Inc is a clinical-stage biotechnology company, which is focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. The Company’s lead clinical program, TSHA-102, is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder. The Company is evaluating TSHA-102 in the REVEALPhase I/II adolescent and adult clinical trial, which is a first-in-human, open-label, randomized, dose escalation and dose-expansion, multicenter study evaluating the safety and preliminary efficacy of TSHA-102 in female patients aged 12-years and older with Rett syndrome. It has acquired a worldwide right to a clinical-stage, intrathecally dosed AAV9 gene therapy program, TSHA-120, for the treatment of giant axonal neuropathy (GAN). It received orphan drug designation from the European Commission for TSHA-120 for the treatment of GAN.

📈 Performance

Price History*

-93.20%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.63

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in TSHA

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

5 days

💵 Average investment amount

$1,637

Last time a customer invested in TSHA

61 days
TSHA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in TSHA also invest in...

Fortinet Inc.

FTNT

🙌 Performance (5Yr p.a)

79.18%

📊 Share price

$99.15 USD
Find Out More

🙌 Performance (5Yr p.a)

58.27%

📊 Share price

$143.63 USD

🙌 Performance (5Yr p.a)

1109.08%

📊 Share price

$183.32 USD

🙌 Performance (5Yr p.a)

919.80%

📊 Share price

$208.91 USD

🙌 Performance (5Yr p.a)

51.94%

📊 Share price

$123.41 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-2.45%

📊 Share price

$5.02 USD
Compare
Add to watchlist